IL-23 favors outgrowth of spondyloarthritis-associated pathobionts and suppresses host support for homeostatic microbiota
Annals of Rheumatic Diseases Feb 02, 2019
Rehaume LM, et al. - Researchers restrained IL-23 in dysbiotic ZAP-70-mutant SKG mice [developed interleukin (IL)-23-dependent spondyloarthropathy (SpA)-like arthritis, psoriasis-like skin inflammation, and Crohn’s-like ileitis in response to microbial beta 1,3-glucan (curdlan)] to analyze the relationship between host IL-23 signaling and gut bacterial dysbiosis in SpA. They observed a decrease in Bacteroidaceae, Porphyromonadaceae, and Prevotellaceae after inhibiting IL-23p19 in naive SKG mice. An inclination in abundance of Clostridiaceae and Lachnospiraceae families and a concomitant decrease was observed in curdlan-mediated SpA development. They noted a relationship between the relative abundance of specific pathobionts with disease severity.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries